Dupilumab Versus Cyclosporine for Treatment of Moderate-To-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index

Acta Dermato-Venereologica - Sweden
doi 10.2340/00015555-3219
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Acta Dermato-Venereologica

Related search

Efficacy and Safety of Dupilumab for the Treatment of Moderate-To-Severe Atopic Dermatitis in Adults

Oncotarget
Oncology
2017English

615 Dupilumab Elicits Rapid and Sustained Improvements in Itch in Adults With Moderate-To-Severe Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Dupilumab for the Treatment of Atopic Dermatitis

Prescriber
Pharmacology
2018English

605 Efficacy and Safety of Dupilumab in Adolescent Patients With Moderate-To-Severe Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

After the Approval of Dupilumab for Moderate-To-Severe Atopic Dermatitis: What Is Next on the Research Agenda?

British Journal of Dermatology
DermatologyMedicine
2018English

621 Dupilumab in Adolescents With Moderate-To-Severe Atopic Dermatitis and a History of Inadequate Response, or Intolerance to Cyclosporine: Subgroup Analysis From a Pivotal 16-Week Trial

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

The European TREatment of ATopic Eczema Taskforce (TREAT) Survey; Prescribing Practices in Europe for Phototherapy and Systemic Therapy in Moderate-To-Severe Adult Atopic Eczema Patients

British Journal of Dermatology
DermatologyMedicine
2020English

Pss18 - Treatment Costs of Atopic Dermatitis in Korean Adults According to Disease Severity

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Dupilumab Treatment Improves Quality of Life in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results From a Randomized, Placebo-Controlled Clinical Trial

British Journal of Dermatology
DermatologyMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy